Liver health and drug safety: new insights on fexinidazole
NCT ID NCT05607173
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 32 times
Summary
This study tested how a single 1200 mg dose of fexinidazole is processed in 21 adults with mild or moderate liver impairment compared to those with normal liver function. The goal was to understand if liver problems change drug levels in the body, which helps doctors decide on safe use. Participants were monitored for drug concentration and tolerability over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC FUNCTION ABNORMAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number: 100-0001
Sofia, 1612, Bulgaria
-
Investigational site 250-0001
Rennes, France
Conditions
Explore the condition pages connected to this study.